NOVO-FOLACID 5MG 5 MG
FOLIC ACID : 5 MG · DIN 00021466 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-FOLACID 5MG?
NOVO-FOLACID 5MG 5 MG contains FOLIC ACID : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 00021466, held by NOVOPHARM LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00021466 |
|---|---|
| Brand name | NOVO-FOLACID 5MG |
| Generic / active ingredient | FOLIC ACID : 5 MG |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | B03BB01 FOLIC ACID |
| AHFS class | 40:28.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2015 |
| Original market date | 1968-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00021466 |
|---|---|
| DIN (unpadded, as printed on some documents) | 21466 |
| Brand name | NOVO-FOLACID 5MG |
| Active ingredient / INN | FOLIC ACID : 5 MG |
| ATC code | B03BB01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B03 |
| AHFS class | 40:28.20 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | NOVOPHARM LIMITED |
Which pack is which?
| Strength on the label | 5 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is FOLIC ACID in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B03BB01 FOLIC ACID. 3 of 37 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FOLIC ACID | Strength | Tablet | AA PHARMA INC UNIT 1 1165 Creditstone Road Vaughan Ontario Canada L4K 4N7 | MARKETED | DIN 00426849 |
| FOLIC ACID INJECTION, USP | 5 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02139480 |
| JAMP-FOLIC ACID | 5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02366061 |
| ACIDE FOLIQUE 5 TAB | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563781 |
| FOLIC ACID | Strength | Capsule | SISU INC. 104A 3430 Brighton Avenue Burnaby British Columbia Canada V5A 3H4 | CANCELLED POST MARKET | DIN 02240313 |
| FOLIC ACID (1MG TABLET) | 1 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 02231643 |
| FOLIC ACID 0.4 MG TABLET | 0.4 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 02241363 |
| FOLIC ACID 0.4MG | 0.4 MG | TABLET | GREAT EARTH COMPANIES, INC. | CANCELLED POST MARKET | DIN 02230603 |
| FOLIC ACID 0.4MG DIETARY SUPPLEMENT | 0.4 MG | TABLET | GARDEN STATE NUTRITIONALS | CANCELLED POST MARKET | DIN 02238506 |
| FOLIC ACID 0.8MG | 0.8 MG | TABLET | GREAT EARTH COMPANIES, INC. | CANCELLED POST MARKET | DIN 02230602 |
Who else supplies FOLIC ACID worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FOLIC ACID appears in 141 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.